Hawaii · 2025 Regular Session · Bill
SB 226: RELATING TO PRESCRIPTION DRUGS.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
SB 226 is a bill introduced in the Hawaii Senate on January 13, 2025. According to its official title, it concerns: RELATING TO PRESCRIPTION DRUGS. Primary sponsor: Brandon Elefante (Democratic), Stanley Chang (Democratic), Lynn DeCoite (Democratic). Most recent recorded action (January 17, 2025): Referred to HHS, CPN.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Establishes requirements for the clinical review criteria and clinical practical guidelines used to establish step therapy protocols. Provides a process for a patient to request an exception to using step therapy protocols. Establishes insurance coverage requirements relating to the use of step therapy protocols and standards to appeal an adverse step therapy exception determination.
Sponsors
Sponsors by party (alphabetical): Democratic 3
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Brandon Elefante | Primary sponsor | Democratic | Senate | 16 |
| Stanley Chang | Primary sponsor | Democratic | Senate | 9 |
| Lynn DeCoite | Primary sponsor | Democratic | Senate | 7 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Referred to HHS, CPN.
- Introduced and passed First Reading.
- Pending Introduction.